Article

Protein biomarkers of adverse clinical features and events in sarcomeric hypertrophic cardiomyopathy.
Tahir, U.A., Kolm, P., Kwong, R.Y., Desai, M.Y., Dolman, S.F., Deng, S., Appelbaum, E., Desvigne-Nickens, P., DiMarco, J.P., Tiwari, G., Friedrich, M.G., Zelaya-Portillo, J.H., Jerosch-Herold, M., Kim, D.Y., Maron, M.S., Piechnik, S.K., Schulz-Menger, J., Watkins, H., Weintraub, W.S., Neubauer, S., Kramer, C.M., Jarolim, P., Gerszten, R.E. and Ho, C.Y.
Circulation Heart Failure 17 (12): e011707. December 2024

Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.
Morris, D.A., Boldt, L.H., Eichstaedt, H., Oezcelik, C. and Haverkamp, W.
Circulation Heart Failure 5 (5): 610-620. September 2012

Review

Cellular interactions and immunometabolic mechanisms in heart failure with preserved ejection fraction: from molecular mechanisms to clinical evidence.
Peikert, Alexander, Vacca, Antonio, Norata, Giuseppe D., Schiattarella, Gabriele G. and Osto, Elena
Circulation Heart Failure : e012674. 2 February 2026 (In Press)

Comment

What exactly is cardiometabolic HFpEF: a phenotype or an endotype?
Packer, Milton, Schiattarella, Gabriele G. and Borlaug, Barry
Circulation Heart Failure : e014031. 23 January 2026 (In Press)